Opus Genetics, a clinical-stage biopharmaceutical company focused on gene therapies for inherited retinal diseases, announced it will participate in a Fireside Chat at the Guggenheim Annual Healthcare Innovation Conference on November 10, 2026. This event highlights the company's ongoing efforts to develop one-time gene therapy treatments aimed at restoring vision and preventing blindness. Investors can access the live and archived webcast through Opus Genetics’ website. The company’s pipeline includes seven programs targeting various genetic causes of retinal disorders, signaling potential advancements in treatment options.
Opus Genetics' upcoming presentation at the Guggenheim Annual Healthcare Innovation Conference provides context for readers following healthcare innovation. As of Nov 03, 2026 19:02 WIB, among 150 priced Health-sector US stocks tradable on Pluang, 74 rose and 69 fell. Notable movers include Koninklijke Philips NV (PHG) at USD 29.23 with a 1-day change of +5.94%, Inovio Pharmaceuticals Inc (INO) at USD 1.78 down -5.56%, and Nuwellis Inc (NUWE) at USD 4.90 down -5.41%.
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...
